4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-13-012636
$NBYCIK 0001389545operating
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:27 PM ET
Size
5.4 KB
Accession
0001437749-13-012636
Insider Transaction Report
Form 4
Najafi Ramin
DirectorChief Executive OfficerOther
Transactions
- Award
Option (right to buy)
2013-09-26−150,000→ 914,852 totalExercise: $1.71From: 2014-09-26Exp: 2023-09-26→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Options granted pursuant to 2007 Omnibus Incentive Plan
- [F2]25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:27 PM ET
- Size
- 5.4 KB